2 Stocks Up Over 700% in 2024 That Could Soar Even Further

These relatively small companies are developing new cancer therapies that could generate billions in annual sales. Investors looking for stocks that can provide dramatic gains found what they were looking for with a pair of cancer drug developers. From the end of 2023 through the closing bell on Sept. 23, shares of Summit Therapeutics and Instil Bio marched over 700% higher. These stocks have outperformed because the new drug candidates they're developing could become some of the most successful cancer trea ...